EUVIMEDEUVIMED entdecken
Crossref

Intratracheally injected human-induced pluripotent stem cell-derived pneumocytes and endothelial cells engraft in the distal lung and ameliorate emphysema in a rat model

Wafa Altalhi, Tong Wu, Gregory R Wojtkiewicz, Sydney Jeffs, Kenji Miki, Harald C Ott

The Journal of Thoracic and Cardiovascular Surgery · 2023

DOI: 10.1016/j.jtcvs.2023.03.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2023. Verfasst von Wafa Altalhi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Mass; Clinical Laboratory Medicine, Faculty of Medical Science…. Hauptthemen laut MEDLINE: Pulmonary Emphysema, Induced Pluripotent Stem Cells, Emphysema. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NIGMS NIH HHS, United Therapeutics Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Pulmonary emphysema is characterized by the destruction of alveolar units and reduced gas exchange capacity. In the present study, we aimed to deliver induced pluripotent stem cell-derived endothelial cells and pneumocytes to repair and regenerate distal lung tissue in an elastase-induced emphysema model. METHODS: We induced emphysema in athymic rats via intratracheal injection of elastase as previously reported. At 21 and 35 days after elastase treatment, we suspended 80 million induced pluripotent stem cell-derived endothelial cells and 20 million induced pluripotent stem cell-derived pneumocytes in hydrogel and injected the mixture intratracheally. On day 49 after elastase treatment, we performed imaging, functional analysis, and collected lungs for histology. RESULTS: Using immunofluorescence detection of human-specific human leukocyte antigen 1, human-specific CD31, and anti--green fluorescent protein for the reporter labeled pneumocytes, we found that transplanted cells engrafted in 14.69% ± 0.95% of the host alveoli and fully integrated to form vascularized alveoli together with host cells. Transmission electron microscopy confirmed the incorporation of the transplanted human cells and the formation of a blood-air barrier. Human endothelial cells formed perfused vasculature. Computed tomography scans revealed improved vascular density and decelerated emphysema progression in cell-treated lungs. Proliferation of both human and rat cell was higher in cell-treated versus nontreated controls. Cell treatment reduced alveolar enlargement, improved dynamic compliance and residual volume, and improved diffusion capacity. CONCLUSIONS: Our findings suggest that human induced pluripotent stem cell-derived distal lung cells can engraft in emphysematous lungs and participate in the formation of functional distal lung units to ameliorate the progression of emphysema.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmphysemaInduced Pluripotent Stem CellsEmphysemaRatsHumansAnimalsAlveolar Epithelial CellsEndothelial CellsLungPancreatic Elastase

Stichwörter der Autor:innen

cell therapydistal lung tissue regenerationemphysemaendothelial cellsinduced pluripotent stem cellspneumocytes

Substanzen

Pancreatic Elastase

Autor:innen und Institutionen

  • Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Mass; Clinical Laboratory Medicine, Faculty of Medical Sciences, Taif University, Taif, Makkah, Saudi Arabia.
  • Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
  • Center for Systems Biology, Massachusetts General Hospital, Boston, Mass.
  • Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Mass. Electronic address: hott@mgh.harvard.edu.

Förderung

  • NIGMS NIH HHS
  • United Therapeutics Corporation

Zitieren

APA

Altalhi, W., Wu, T., Wojtkiewicz, G. R., Jeffs, S., Miki, K., & Ott, H. C. (2023). Intratracheally injected human-induced pluripotent stem cell-derived pneumocytes and endothelial cells engraft in the distal lung and ameliorate emphysema in a rat model. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2023.03.009

Vancouver

Altalhi W, Wu T, Wojtkiewicz GR, Jeffs S, Miki K, Ott HC. Intratracheally injected human-induced pluripotent stem cell-derived pneumocytes and endothelial cells engraft in the distal lung and ameliorate emphysema in a rat model. The Journal of Thoracic and Cardiovascular Surgery. 2023. doi:10.1016/j.jtcvs.2023.03.009

BibTeX
@article{Altalhi2023,
  author = {Altalhi, Wafa and Wu, Tong and Wojtkiewicz, Gregory R and Jeffs, Sydney and Miki, Kenji and Ott, Harald C},
  title = {Intratracheally injected human-induced pluripotent stem cell-derived pneumocytes and endothelial cells engraft in the distal lung and ameliorate emphysema in a rat model},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2023},
  doi = {10.1016/j.jtcvs.2023.03.009}
}
Kostenlos starten →